Lyra Therapeutics Competitors and Similar CompaniesClear all
Intersect ENT's competitors and similar companies include Spur Therapeutics.
 Intersect ENT Intersect ENT (also known as Medtronic Ear, Nose & Throat) is an ear, nose, and throat medical technology company. |  Spur Therapeutics Spur Therapeutics (formerly known as Freeline) is a clinical-stage biotechnology company that develops transformative gene therapies. | |
Founding Date | Founding Date 2003 | Founding Date 2015 |
Type | Type Subsidiary | Type Subsidiary |
Tags | ||
Locations | Locations Menlo Park, US HQ | Locations Stevenage, GB HQ Boston, US New York, US |
Employees | Employees 4337% increase | Employees 122 |
Financial | ||
Revenue (est.) | Revenue (est.) $106.7m (FY, 2021) | Revenue (est.) N/A |
Cost of goods | Cost of goods $30m (FY, 2021) | Cost of goods N/A |
Gross profit | Gross profit $76.7m (FY, 2021) | Gross profit $8.9m (FY, 2022) |
Net income | Net income ($159.6m) (FY, 2021) | Net income ($89m) (FY, 2022) |
Operating ⚠ | ||
Trademarks | Trademarks 29 (FY, 2016) | Trademarks 14 (May, 2024) |
Funding | ||
Total funding raised | Total funding raised $ 102.9m | Total funding raised $ 289.3m |
For sources of this data, please see the company profile
View Company Profiles
Spur Therapeutics
HQ
Stevenage, GB
Spur Therapeutics (formerly known as Freeline) is a clinical-stage biotechnology company that develops transformative gene therapies.
View company